Wells Fargo’s Protalix BioTherapeutics PLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.3K | Buy |
+36,034
| New | +$53.3K | ﹤0.01% | 5065 |
|
|
2024
Q2 | – | Sell |
-23,369
| Closed | -$29.4K | – | 6854 |
|
|
2024
Q1 | $29.4K | Buy |
23,369
+3,439
| +17% | +$4.33K | ﹤0.01% | 5076 |
|
|
2023
Q4 | $35.5K | Buy |
19,930
+4,010
| +25% | +$7.14K | ﹤0.01% | 4976 |
|
|
2023
Q3 | $26.4K | Sell |
15,920
-5,074
| -24% | -$8.42K | ﹤0.01% | 5121 |
|
|
2023
Q2 | $42K | Buy |
+20,994
| New | +$42K | ﹤0.01% | 5208 |
|
|
2019
Q2 | – | Sell |
-700
| Closed | – | – | 6097 |
|
|
2019
Q1 | $0 | Hold |
700
| – | – | ﹤0.01% | 6012 |
|
|
2018
Q4 | $0 | Sell |
700
-100,000
| -99% | – | ﹤0.01% | 5984 |
|
|
2018
Q3 | $73K | Hold |
100,700
| – | – | ﹤0.01% | 5211 |
|
|
2018
Q2 | $43K | Hold |
100,700
| – | – | ﹤0.01% | 5351 |
|
|
2018
Q1 | $54K | Hold |
100,700
| – | – | ﹤0.01% | 5257 |
|
|
2017
Q4 | $67K | Hold |
100,700
| – | – | ﹤0.01% | 5193 |
|
|
2017
Q3 | $58K | Hold |
100,700
| – | – | ﹤0.01% | 5150 |
|
|
2017
Q2 | $84K | Hold |
100,700
| – | – | ﹤0.01% | 5006 |
|
|
2017
Q1 | $137K | Buy |
100,700
+100,000
| +14,286% | +$136K | ﹤0.01% | 4827 |
|
|
2016
Q4 | $0 | Hold |
700
| – | – | ﹤0.01% | 5932 |
|
|
2016
Q3 | $0 | Hold |
700
| – | – | ﹤0.01% | 5920 |
|
|
2016
Q2 | $0 | Hold |
700
| – | – | ﹤0.01% | 5903 |
|
|
2016
Q1 | $1K | Hold |
700
| – | – | ﹤0.01% | 5824 |
|
|
2015
Q4 | $1K | Hold |
700
| – | – | ﹤0.01% | 5786 |
|
|
2015
Q3 | $1K | Buy |
+700
| New | +$1K | ﹤0.01% | 5762 |
|